Relaciones hipertensión arterial esencial-osteoporosis: Impacto del tratamiento antihipertensivo sobre el metabolismo extracelular del calcio

Revista Clinica Espanola

Volumn 199, Issue 8, 1999, Pages 523-529

  Pérez, J Honorato ^a   Escolar Jurado, M ^a   Garcia Quetglas E ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; CALCIUM ANTAGONIST; CALCIUM ION; CAPTOPRIL; DIHYDROXYCOLECALCIFEROL; ENALAPRIL; HYDROXYPROLINE; PARATHYROID HORMONE; QUINAPRIL;

ADULT; AGED; ANIMAL; BONE DENSITY; CALCIUM INTAKE; CLINICAL TRIAL; COMPARATIVE STUDY; EXERCISE; EXTRACELLULAR SPACE; FEMALE; HUMAN; HYPERTENSION; MALE; METABOLISM; OSTEOPOROSIS; RAT; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; CALCIUM METABOLISM; EXTRACELLULAR CALCIUM; FITNESS; FRACTURE; NONHUMAN; PROGNOSIS;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BONE DENSITY; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM, DIETARY; CLINICAL TRIALS; DIURETICS; EXERCISE; EXTRACELLULAR SPACE; FEMALE; HUMANS; HYPERTENSION; MALE; OSTEOPOROSIS; RATS; RATS, INBRED SHR;

EID: 0039627813     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Johnson B, Christiansen C, Johnell O, Hedbrandt J, Karlsson G. Cost-effectiveness of fracture prevention in established osteoporosis. Scand J Rheumatol 1996; 103 (suppl):30-38.
2. McCarron DA, Pingree PA, Rubin RJ, Gaucher SM, Molitch M, Krutzik S. Enhanced parathyroid function in essential hypertension: a homeostasis response to a urinary calcium leak. Hypertension 1980; 2:162-168.
3. Strazullo P, Nunziata V, Cirillo M, Giannattasio R, Ferrera LA, Mattioli PL. Abnormalities of calcium metabolism in essential hypertension. Clin Sci 1983; 65:137-141.
4. Grobbee DE, Hackeng WHL, Birkenhäger JC, Hofman A. Raised plasma intact parathyroid hormone concentrations in young people with midly raised blood pressure. Br Med J 1988; 296:814-816.
5. Brickman AS, Nyby MD, Von Hungen K, Eggena P, Tuck ML. Calciotropic hormones, platelet calcium and blood pressure in essential hypertension. Hypertension 1990; 16:515-522.
6. Resnick LM. Uniformity and diversity of calcium metabolism in hypertension: a conceptual framework. Am J Med 1987; 82 (suppl 1B):16-26.
7. Vincenzi FF, Morris CD, Kinsel LB, McCarron DA. Decreased calcium pump adenosine triphosphatase in red blood cells of hypertensive subjects. Hypertension 1986; 8:1.058-1.066.
8. 2+ pump in erythrocytes from essential hypertensive patients. J Hypertens 1990; 8:285-293.
9. Reichel H, Liebethal R, Hense HW, Schmidt-Gayk H, Ritz E. Disturbed calcium metabolism in subjects with elevated diastolic blood pressure. Clin Invest 1992; 70(9):748-751.
10. Young EW, Morris CD, McCarron DA. Urinary calcium excretion in essential hypertension. J Lab Clin Med 1992; 120:624-632.
11. Tillman DM, Semple PF. Calcium and magnesium in essential hypertension. Clin Sci 1988; 75:395-402.
12. Gadallah M, Massry SG, Bigazzi R, Horst RL, Eggena P, Campese VM. Intestinal absorption of calcium and calcium metabolism in patients with essential hypertension and normal renal function. Am J Hypertens 1991; 4:404-409.
13. Resnick LM, Müller FB, Laragh JH. Calcium regulatory hormones in essential hypertension: relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986; 105:649-654.
14. Kurtz TW, Curtis Morris R Jr. Sodium-calcium interactions and salt-sensitive hypertension. Am J Hypertens 1990; 3 (suppl): 152S-155S.
15. Cappuccio FP, Blackwood A, Sagnella GA, Markandu ND, MacGregor GA. Association between extracellular volume expansion and urinary calcium excretion in normal humans. J Hypertens 1993; 11(S5):S196-S197.
16. Short C, Flynn A. Sodium-calcium inter-relationships with specific reference to osteoporosis. Nutr Res Rev 1990; 3:101-115.
17. Galletti F, Rutledge A, Triggle DJ. Dietary sodium intake influence on calcium channels and urinary calcium excretion in spontaneously hypertensive rats. Biochem Pharmacol 1991; 41:893-896.
18. McGregor GA, Capuccio FP. The kidney and essential hypertension: a link to osteoporosis? J Hypertens 1993; 11:781-785.
19. Lind L, Lithell H, Gustafsson IB, Pollare T, Ljunghall S. Calcium metabolism and sodium sensitivity in hypertensive subjects. J Hum Hypertens 1993; 7(1):53-57.
20. Yamakawa H, Suzuki H, Nakamura M, Ohno Y, Sarutta T. Disturbed calcium metabolism in offspring of hypertensive parents. Hypertension 1992; 19:528-534.
21. McParland BE, Goulding A, Campbell AJ. Dietary salt affects biochemical markers of resorption and formation of bone in elderly women. Br Med J 1989; 299:834-835.
22. Evans CE, Chughtai AY, Blumsohn A, Giles M, Eastell R. The effect of dietary sodium on calcium metabolism in premenopausal and postmenopausal women. Eur J Clin Nutr 1997; 51:394-399.
23. Zhou CH, Fran S, Zhou L, Ni Y, Huang T, Shi Y. Clinical observation of treatment of hypertension with calcium. Am J Hypertens 1994; 7:363-367.
24. Sallinen K, Arvola P, Wuorela H, Ruskoaho H, Vapaatalo H, Porsti I. High calcium diet reduces blood pressure in exercised and non exercised hypertensive rats. Am J Hypertens 1996; 9 (2): 144-156.
25. Hatton DC, McCarron DA. Dietary calcium and blood pressure in experimental models of hypertension. A review. Hypertension 1994; 23(4):513-530.
26. Porsti I, Makynen H. Dietary calcium intake: effects on central blood pressure control. Semin Nephrol 1995; 15 (6):550-563.
27. Schleiffer R, Galluser M, Kachelhoffer J, Raul F. Dietary calcium supplementation, blood pressure and intestinal calcium absorption. Am J Med Sci 1994; 307(S1):S16-S119.
28. Barger-Lux MJ, Heaney RP. The role of calcium intake in preventing bone fragility, hypertension, and certain cancers. J Nutr 1994; 124 (8 suppl):1.406S-1.411S.
29. Sánchez M, De la Sierra A, Coca A, Poch E, Giner V, Urbano-Márquez A. Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. Hypertension 1997; 29 (1 pt 2):531-536.
30. Physical exercise in the management of hypertension: a consensus statement by the World Hypertension League. J Hypertens 1991; 9:283-287.
31. Barlet JP, Coxam V, Davicco MJ. Exercise physique et squelette. Arch Physiol Biochem 1995; 103:681-698.
32. Fentem PH. Exercise in prevention of disease. Br Med Bull 1992; 48:630-650.
33. Fagard RH. The role of exercise in blood pressure control: supportive evidence. J Hypertens 1995; 13:1.223-1.227.
34. Staessen JA, Fagard R, Amery A. Life style as a determinant of blood pressure in the general population. Am J Hypertens 1994; 7:685-694.
35. Geleijnse JM, Witeman JC, DenBreisen JH, et al. Dietary electrolyte intake and blood pressure in older subjects: the Rotterdam study. J Hypertens 1996; 14(6):737-741.
36. Lemann J, Pleuss JA, Gray RW, Hoffmann RG. Potasium administration increase and potassium deprivation reduces urinary calcium excretion in healthy adults. Kidney Int 1991; 39:973-983.
37. Lewanczuk RZ, Benishin CG, Shan J, Pang PKT. Clinical aspects of parathyroid hypertensive factor. J Cardiovasc Pharmacol 1994; 23 (S2):S23-S26.
38. Ahaneku JE, Taylor GO, Walker O, Agbedana EO, Sowunmi A, Salako LA. Biochemical changes during amlodipine treatment in hypertensive patients. Eur J Clin Pharmacol 1994; 46:249-251.
39. Fagher B, Henningsen N, Hulthen L, Katzman P, Thulin T. Antihypertensive and renal effects of enalapril and slow-release verapamil in essential hypertension. Eur J Clin Pharmacol 1990 (suppl 12):S41-S43.
40. Lind L, Hanni A, Hvarfner A, Pollare T, Ljunghall S, Lithell H. Influences of different antihypertensive treatments on indices of systemic mineral metabolism. Am J Hypertens 1994; 7:302-307.
41. Puig JG, Mateos FA, Ramos TH, Lavilla MP, Capitan MC, Gil A. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors. Am J Hypertens 1994; 7:46-51.
42. LaCroix AZ, Wienpahl J, White LR, Wallace RB, Scherr PA, George LK. Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med 1990; 322:286-290.
43. Wasnich R, Davis J, Ross P, Vogel J. Effect of thiazide on rates of bone mineral loss: a longitudinal study. Br Med J 1990; 301:1.303-1.305.
44. Wasnich RD, Benfante RJ, Yano K, Heilbrum L, Vogel JM. Thiazide effect on the mineral content of bone. N Engl J Med 1983; 309:344-347.
45. Riera G, González F. Efecto de dosis bajas de tiazidas en la homeostasis de magnesio y potasio en hipercalciuria idiopática. Nefrología 1994; 14:66-71.
46. Garcia Puig J, Miranda ME, Mateos F, Herrero E, Lavilla P, Gil A. Hydrochlorotiazide versus spironolactone: long-term metabolic modifications in patients with essential hypertension. J Clin Pharmacol 1991; 31:455-461.
47. Fanestil DD, Vaughn DA, Ma L, Hyde RH, Printz MP. Thiazide diuretics normalize urinary calcium in spontaneously hypertensive male rats. Kidney Int 1997; 51:1.018-1.021.
48. Pierce RO, Perry A. The effects of thiazide diuretics on bone mineral metabolism. J Natl Med Assoc 1998; 90:46-50.
49. Kamijo T, Gonzalez JM, Jost LJ, Barrios R, Suki WN. Renal abnormality of calcium handling in spontaneously hypertensive rats. Kidney Int 1996; 49 (S55):S166-S168.
50. Friedman PA, Gesek FA. Calcium transport in renal epithelial cells. Am J Physiol 1993; 264:F181-F198.
51. Barry EL, Gesek FA, Kaplan MR, Herbert SC, Friedman PA. Expression of the sodium-chloride cotransporter in osteoblast-like cells: effect of thiazide diuretics. Am J Physiol 1997; 272:C109-C116.
52. Reusz GS, Dobos M, Vasarhelyi B, et al. Sodium transport and bone mineral density in hypercalciuria with thiazide treatment. Pediatr Nephrol 1998; 12(1):30-34.
53. Wasnich R, Davis J, Ross P, Vogel J. Effect of thiazide on rates of bone mineral loss: a longitudinal study. Br Med J 1990; 301:1.303-1.305.
54. Feskanich D, Willet WC, Stampfer MJ, Golditz GA. A prospective study of thiazide use and fractures in women. Osteoporosis Int 1997; 7:79-84.
55. La Croix AZ, Wienpahl J, White LR, et al. Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med 1990; 322:286-290.
56. Wasnich RD, Davis JW, He YF, Petrovich H, Ross PD. A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women. Osteoporosis Int 1995; 5 (4):247-251.
57. Jones G, Nguyen T, Sambrook PN, Eisman JA. Thiazide diuretics and fractures: can meta-analysis help? J Bone Miner Res 1995; 10 (1):106-111.
58. Jergas M, Kosow A, Uffmann M, Schmutz G, Bockenforde JB, Gluer CC, Koster O. The effect of a low-dose hydrochlorothiazide therapy on the bone mineral content of the axial and peripheral skeleton. Deutsch Med Wochenschr 1994; 119 (48):1.645-1.652.
59. Morton DJ, Barrett-Connor EL, Edelstein SL. Thiazides and bone mineral density in elderly men and women. Am J Epidemiol 1994; 139 (11):1.107-1.115.
60. Jeunemaitre X, Chatellier G, Kreft-Jais C, et al. Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol 1987; 60:820-825.
61. Costanzo LS. Comparison of calcium and sodium transport in early and late distal tubules. Effect of amiloride. Am J Physiol 1984; 246:F937-F945.